Societal preference values for advanced melanoma health states in the United Kingdom and Australia.
Beusterien KM. et al, (2009), Br J Cancer, 101, 387 - 389
Chemotherapy-based treatment of metastatic melanoma
Atkins MB. et al, (2009), Cutaneous Melanoma, Fifth Edition
A phase I study of pazopanib in combination with FOLFOX 6 or capeOx in subjects with colorectal cancer.
Brady J. et al, (2009), J Clin Oncol, 27
A phase I study of pazopanib in combination with FOLFOX 6 or capeOx in subjects with colorectal cancer
Brady J. et al, (2009), JOURNAL OF CLINICAL ONCOLOGY, 27
Phase II trial of nemorubicin hydrocloride (nemorubicin) in combination with cisplatin (cDDP) in patients (pts) with hepatocellular carcinoma (HCC): First step results
Izzo F. et al, (2009), JOURNAL OF CLINICAL ONCOLOGY, 27
A phase I study of extended dosing with lomeguatrib with temozolomide in patients with advanced melanoma.
Kefford RF. et al, (2009), Br J Cancer, 100, 1245 - 1249
O(6)-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatrib.
Watson AJ. et al, (2009), Br J Cancer, 100, 1250 - 1256
Phase I study of the poly(ADP-ribose) polymerase inhibitor, AG014699, in combination with temozolomide in patients with advanced solid tumors.
Plummer R. et al, (2008), Clin Cancer Res, 14, 7917 - 7923
Phase I study of copper-binding agent ATN-224 in patients with advanced solid tumors.
Lowndes SA. et al, (2008), Clin Cancer Res, 14, 7526 - 7534
ADJUVANT BEVACIZUMAB IS SAFE TREATMENT FOR MELANOMA PATIENTS AT HIGH RISK OF RECURRENCE
Biswas S. et al, (2008), ANNALS OF ONCOLOGY, 19, 245 - 245
High-intensity focused ultrasound ablation of liver tumours: can radiological assessment predict the histological response?
Leslie TA. et al, (2008), Br J Radiol, 81, 564 - 571
Phase I pharmacokinetic and pharmacodynamic study of the prenyl transferase inhibitor AZD3409 in patients with advanced cancer.
Appels NMGM. et al, (2008), Br J Cancer, 98, 1951 - 1958
A phase II study of PTK787 in metastatic melanoma patients.
Corrie P. et al, (2008), J Clin Oncol, 26
A phase II study of PTK787 in metastatic melanoma patients
Corrie P. et al, (2008), JOURNAL OF CLINICAL ONCOLOGY, 26
A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer.
Khan OA. et al, (2008), Br J Cancer, 98, 1614 - 1618
AZD6244 (ARRY-142886) vs temozolomide (TMZ) in patients (pts) with advanced melanoma: An open-label, randomized, multicenter, phase II study.
Dummer R. et al, (2008), J Clin Oncol, 26
AZD6244 (ARRY-142886) vs temozolomide (TMZ) in patients (pts) with advanced melanoma: An open-label, randomized, multicenter, phase II study
Dummer R. et al, (2008), JOURNAL OF CLINICAL ONCOLOGY, 26